The FDA also notes that no safety-related information regarding DSIP has been identified, so its unknown whether it could be harmful to humans.26 Given these conclusions, we shouldnt be surprised that DSIP is not an FDA-approved peptide therapy
Without sufficient levels of this nutrient, people might experience bone pain and muscle weakness, and children could develop rickets, a condition leading to bone deformities
[16] Although cyanocobalamin lacks a defined upper-toxicity threshold due to its water solubility and renal elimination, exceptionally high cumulative doses have been temporally associated with acneiform eruptions, altered potassium homeostasis, and theoretical thrombotic risk, emphasizing the importance of evidence-based dosing
The FDA has raised concerns about purity, immune reactions and the lack of human research
AminoVault markets itself as a US-based research peptide manufacturer that pairs cGMP-compliant manufacturing with ISO/IEC 17025 testing and states 99%+ purity across its catalog
Sermorelin has pharma versions but expensive